
Latest Search

Quote
Back Zoom + Zoom - | |
WUXI BIO Major Shareholder Sells 82.94M Shrs at 5% Discount, Cashing in HKD2.2B+
Recommend 11 Positive 21 Negative 15 |
|
![]() |
|
WUXI BIO (02269.HK) announced that Biologics Holdings, controlled by Chairman and Non-executive Director Ge Li, a major shareholder of the Company, entered into a Block Trade Agreement with the Placement Agent Morgan Stanley on June 14. The Agreement involves the placing of 82.94 million existing shares of the Company, representing approximately 2.04% of the Company's issued share capital, at a price of HKD26.6 per share, representing a 5% discount to its closing price of HKD28 last Friday (13th). The transaction is expected to cash in HKD2.206 billion. Upon completion of the Placing, Biologics Holdings' stake in WUXI BIO will decrease from approximately 14.36% to 12.32%, remaining a major shareholder of the company. AASTOCKS Financial News Website: www.aastocks.com |
|